Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Implication of Hypoxia-Inducible Factor-1 (HIF-1) As a New Therapeutic Target in JAK2 V617F Positive Myeloproliferative Neoplasms (MPN)

Julian Baumeister, MSc, Nicolas Chatain, PhD, Annika Hubrich, Caroline Küstermann, M.Sc., Stephanie Sontag, PhD, Kristin Seré, PhD, Martin Zenke, PhD, Tim H Brümmendorf, MD, Kamil Kranc, MD, Steffen Koschmieder, MD, Deniz Gezer, MD

Blood (2018) 132 (Supplement 1): 4318.

https://doi.org/10.1182/blood-2018-99-113332

Published: 2018

Journal Articles

Novel Myelodysplastic Syndromes-like Mouse Models By Cooperating Genetic/Epigenetic Mutations Reveal the Critical Role of HIF-1α for Disease Development

Yoshihiro Hayashi, MD PhD, Yue Zhang, MD, Xiaomei Yan, MD PhD, Goro Sashida, MD PhD, Zefeng Xu, MD, Yunzhu Dong, Hironori Harada, MD PhD, Zhijian Xiao, MD, Gang Huang, PhD

Blood (2014) 124 (21): 362.

https://doi.org/10.1182/blood.V124.21.362.362

Published: 2014

Journal Articles

Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells

Yin Wang, Yan Liu, Fei Tang, Kelsie M. Bernot, Reuven Schore, Guido Marcucci, Michael A. Caligiuri, Pan Zheng, Yang Liu

Blood (2014) 124 (7): 1127–1135.

https://doi.org/10.1182/blood-2013-12-544221

Published: 2014

Includes: Supplemental data

Journal Articles

HIF-1 Prevents Hematopoietic Cells from Cell Damage by Overproduction of Mitochondrial ROS after Cytokine Stimulation through Induction of PDK-1

Keita Kirito, MD, Kozue Yoshida, Yongzhen Hu, Qiao Qiao, Kumi Sakoe, Norio Komatsu

Blood (2008) 112 (11): 2435.

https://doi.org/10.1182/blood.V112.11.2435.2435

Published: 2008

Journal Articles

HIF-1 Supports the Survival of Multiple Myeloma Cells through the Induction of Survivin Gene.

Keita Kirito, MD, PhD, Hu Yongzhen, MD, Kozue Yoshida, MD, Toru Mitsumori, MD, Kei Nakajima, MD, Yumi Nozaki, MD, Takahiro Nagashima, MD, Masae Kunitama, MD, Kumi Sakoe, PhD, Norio Komatsu, MD, PhD

Blood (2007) 110 (11): 110.

https://doi.org/10.1182/blood.V110.11.110.110

Published: 2007

NARROW

Implication of Hypoxia-Inducible Factor-1 (HIF-1) As a New Therapeutic Target in JAK2 V617F Positive Myeloproliferative Neoplasms (MPN)

Novel Myelodysplastic Syndromes-like Mouse Models By Cooperating Genetic/Epigenetic Mutations Reveal the Critical Role of HIF-1α for Disease Development

Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells

HIF-1 Prevents Hematopoietic Cells from Cell Damage by Overproduction of Mitochondrial ROS after Cytokine Stimulation through Induction of PDK-1

HIF-1 Supports the Survival of Multiple Myeloma Cells through the Induction of Survivin Gene.

Email alerts

ASH Publications

American Society of Hematology

Implication of Hypoxia-Inducible Factor-1 (HIF-1) As a New Therapeutic Target in JAK2 V617F Positive Myeloproliferative Neoplasms (MPN)

Novel Myelodysplastic Syndromes-like Mouse Models By Cooperating Genetic/Epigenetic Mutations Reveal the Critical Role of HIF-1α for Disease Development

Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells

HIF-1 Prevents Hematopoietic Cells from Cell Damage by Overproduction of Mitochondrial ROS after Cytokine Stimulation through Induction of PDK-1

HIF-1 Supports the Survival of Multiple Myeloma Cells through the Induction of Survivin Gene.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only